The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
The present study revealed that the concomitant use of ertugliflozin has favorable effects on liver enzymes, as it decreases liver fat intake and reduces complications in patients with NAFLD-associated T2DM. However, more in-depth studies will be required to observe every aspect of ertugliflozin.
Authors
- Long Chiau Ming (ORCID: https://orcid.org/0000-0002-6971-1383)
- Adil Khaliq (ORCID: https://orcid.org/0000-0003-3887-5980)
- Haroon Badshah (ORCID: https://orcid.org/0000-0003-2959-0414)
- Maong Hui Cheng
- Inayat Ur Rehman (ORCID: https://orcid.org/0000-0002-8657-9791)
- Kashif Ullah Khan (ORCID: https://orcid.org/0000-0002-1934-1521)
- Yasar Shah (ORCID: https://orcid.org/0000-0001-9354-8187)
Institutions
- Abdul Wali Khan University Mardan (PK)
- University of Malaya (MY)
- Sunway University (MY)
Publication Details
- Journal
- Medicine
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1097/md.0000000000040356
- Citations
- 15
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.80
Funders
- Abdul Wali Khan University Mardan